SCHEMBL3853829

SCHEMBL3853829

C[C@]12CC[C@H]3[C@@H](CCC4CC(O)CC[C@@H]43)[C@@H]1C[C@@H](O)C2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.41
GRIN2B Q13224 2/20 0.41
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRA3 P34903 2/20 0.35
GABRA2 P47869 2/20 0.35
GABRB2 P47870 2/20 0.35
GABRA4 P48169 2/20 0.35
GABRE P78334 2/20 0.35
GABRA6 Q16445 2/20 0.35
GABRG1 Q8N1C3 2/20 0.35
GABRG3 Q99928 2/20 0.35
GABRQ Q9UN88 2/20 0.35
SHBG P04278 1/20 0.35
NR1I3 Q14994 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26304098 1.00 GRIN1 (0.41) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL133513 0.81 GRIN1 (0.60) GRIN1GRIN2BSHBGNR1I3
SCHEMBL6812629 0.81 GRIN1 (0.60) GRIN1GRIN2BSHBGNR1I3
SCHEMBL22018389 0.81 GRIN1 (0.60) GRIN1GRIN2BSHBGNR1I3
SCHEMBL13007746 0.81 GRIN1 (0.60) GRIN1GRIN2BSHBGNR1I3
SCHEMBL4640991 0.79 GABRP (0.36) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL15963546 0.76 SHBG (0.45) GRIN1GRIN2BSHBG
SCHEMBL17340849 0.76 GRIN1 (0.42) GRIN1GRIN2BSHBG
SCHEMBL15963554 0.76 SHBG (0.45) GRIN1GRIN2BSHBG
SCHEMBL15963427 0.76 SHBG (0.45) GRIN1GRIN2BSHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2039702-A2 Prodrugs erbeta-selective substances, method for their production and pharmaceutical compounds containing these compositions Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-25 EP claimed